Back

The combination of ipragliflozin and losartan preserves cardiac function in a rat experimental autoimmune myocarditis model

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Immune modulation and inflammatory pathways in cardiovascular disease and myocarditis Leukocytes, Inflammation, Immunity ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Lupiya Kimena

Mie University, Tsu (Japan)

6 More presentations in this session

Presentation thumbnail
Cardioprotective effect of genetic deletion of Atg5 gene or pharmacological autophagy inhibition in mouse model of experimental autoimmune myocarditis
Mrs M. Czepiec (Cracow, PL)
Abstract Slides Video
Presentation thumbnail
Soluble ST2-associated protein induces cardiac injury by inhibiting mitochondrial ETC gene expression in cardiomyocytes in fulminant myocarditis
Doctor Y. Zhuang (Wuhan, CN)
Abstract Slides Video
Presentation thumbnail
Large-scale and comprehensive analysis of the associations between immune cell traits and cardiovascular disease risks
Doctor J. Ma (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Anti-inflammatory protection of early vs delayed sodium-glucose cotransporter-2 inhibitor therapy on monocyte-derived macrophages from patients with type2 diabetes with acute myocardial infarction.
Miss J. Ward (Lincoln, GB)
Abstract Slides Video
Presentation thumbnail
Hydroxychloroquine cures autoimmune myocarditis by inhibiting innate immune via the CXCL16-CXCR6 axis between macrophages and T cells
Professor D. Wang (Wuhan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Immune modulation and inflammatory pathways in cardiovascular disease and myocarditis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session
thumbnail
Congress Session
Novel targets against myocardial damage
thumbnail
Congress Session
Further Insights into SGLT2i treatment for heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources